Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 5/20 | 0.55 |
| ▸ | P2RY1 | P47900 | 9/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | AMPD2 | Q01433 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31191390 | 0.84 | P2RY1 (0.43) | NOTUMP2RY1XIAPBIRC2PDE4B | |
| SCHEMBL30039456 | 0.77 | XIAP (0.58) | NOTUMXIAPBIRC2 | |
| SCHEMBL14823131 | 0.76 | NOTUM (0.65) | NOTUMXIAPBIRC2 | |
| SCHEMBL17446870 | 0.76 | NOTUM (0.57) | NOTUMXIAPBIRC2 | |
| SCHEMBL10289631 | 0.76 | NOTUM (0.60) | NOTUMXIAPBIRC2AMPD2 | |
| SCHEMBL8957579 | 0.76 | NOTUM (0.60) | NOTUMXIAPBIRC2 | |
| SCHEMBL17436116 | 0.75 | NOTUM (0.63) | NOTUMXIAPBIRC2 | |
| SCHEMBL17636177 | 0.75 | NOTUM (0.63) | NOTUMXIAPBIRC2AMPD2 | |
| SCHEMBL10257474 | 0.75 | NOTUM (0.63) | NOTUMXIAPBIRC2 | |
| SCHEMBL31191380 | 0.75 | PDE4B (0.41) | NOTUMP2RY1XIAPBIRC2PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720034-A1 | NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS | Zydus Lifesciences Limited (IN) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024252254-A1 | NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS | ZYDUS LIFESCIENCES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |